Biomics Biopharma (ASX:BBM) Total Receivables: A$0.00 Mil (As of . 20)


What is Biomics Biopharma Total Receivables?

Biomics Biopharma ASX:BBM Total Receivables is A$0.00 Mil as of . 20.

Biomics Biopharma's Total Receivables for the quarter that ended in . 20 was A$0.00 Mil.

Biomics Biopharma Total Receivables Related Terms

Biomics Biopharma Total Receivables Historical Data

* Premium members only.

The historical data trend for Biomics Biopharma's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biomics Biopharma Total Receivables Chart

Biomics Biopharma Annual Data
Trend
Total Receivables

Biomics Biopharma Semi-Annual Data
Total Receivables

Biomics Biopharma Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of A$0.00 Mil mean?
Biomics Biopharma (ASX:BBM) has a Total Receivables of A$0.00 Mil as of . 20. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Biomics Biopharma and its competitors.
Is Biomics Biopharma's Total Receivables too high?
Biomics Biopharma's current Total Receivables is A$0.00 Mil.
How does Biomics Biopharma's Total Receivables compare to competitors?
Biomics Biopharma's Total Receivables of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Biotechnology company?
A good Total Receivables depends on the Biotechnology industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Biomics Biopharma and its competitors. Biomics Biopharma's current Total Receivables is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biomics Biopharma stock overvalued right now?
Biomics Biopharma (ASX:BBM) has a current Total Receivables of A$0.00 Mil. The current Total Receivables is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Biomics Biopharma (ASX:BBM), the current Total Receivables is A$0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biomics Biopharma Business Description

Address 1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000
Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.